FAST NEWS: Burning Rock’s cancer test gets breakthrough designation
The latest: Cancer screening company Burning Rock Biotech Ltd. (BNR.US) announced Sunday that its OverC multi-cancer detection blood test (MCDBT) has been granted breakthrough device designation by the China National…
RELATED ARTICLES
- Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
BRIEF: Burning Rock returns to revenue growth as loss narrows
BNR.US
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
CARsgen seeks cell therapy breakthrough but stays in the red for now
2171.HK
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
-
A blockbuster cancer drug? TYK’s claims go under the microscope
2410.HK
Discover hidden China stock gems in our weekly newsletter